Skye Bioscience, Inc.SKYENASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank92
3Y CAGR+45.9%
5Y CAGR+60.3%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+45.9%/yr
vs +46.9%/yr prior
5Y CAGR
+60.3%/yr
Recent deceleration
Acceleration
-1.0pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
10.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$28.31M-61.1%
2024$72.76M+509.4%
2023$11.94M+31.1%
2022$9.11M-7.5%
2021$9.86M+268.9%
2020$2.67M+33.8%
2019$2.00M+2.0%
2018$1.96M+251.2%
2017$557218.00+72.3%
2016$323363.00-